Cargando…

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease

Purpose: Evaluate the safety and efficacy of cryopreserved amniotic cytokine extract (ACE) in the treatment of subjects with dry eye disease (DED). Patients and methods: This was a retrospective, multicenter, chart review of adult patients with DED that instilled cryopreserved ACE drops twice-daily...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeu, Elizabeth, Goldberg, Damien F, Mah, Francis S, Beckman, Kenneth A, Luchs, Jodi I, Solomon, Jonathan D, White, Darrell E, Gupta, Preeya K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549774/ https://www.ncbi.nlm.nih.gov/pubmed/31213759 http://dx.doi.org/10.2147/OPTH.S203510

Ejemplares similares

Making the diagnosis of Sjögren’s syndrome in patients with dry eye
por: Beckman, Kenneth A, et al.
Publicado: (2015)

The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline
por: Vickers, Laura A., et al.
Publicado: (2015)

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies
por: Shen Lee, Bridgitte, et al.
Publicado: (2020)

Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment
por: Milner, Mark S., et al.
Publicado: (2017)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald, Marguerite B, et al.
Publicado: (2018)

Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis
por: Mead, Olivia G., et al.
Publicado: (2020)

Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients
por: Kim, Michelle J, et al.
Publicado: (2017)

Dry Eye Disease: Consideration for Women's Health
por: Matossian, Cynthia, et al.
Publicado: (2019)

Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
por: Godin, Morgan R, et al.
Publicado: (2017)

Loteprednol Etabonate for the Treatment of Dry Eye Disease
por: Beckman, Kenneth, et al.
Publicado: (2020)

The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flares
por: Gupta, Preeya K., et al.
Publicado: (2021)

Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
por: Venkateswaran, Nandini, et al.
Publicado: (2022)

A Pilot Study of the Short Term Effectiveness and Safety of Amniotic Fluid in Severe Dry Eye Disease
por: CHEN, Ming, et al.
Publicado: (2019)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
por: Tauber, Joseph, et al.
Publicado: (2018)

Changes in preoperative corneal measurements following same-day intraocular pressure testing with rebound tonometry
por: Beckman, Kenneth A., et al.
Publicado: (2020)

Late-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture
por: Beckman, Kenneth A., et al.
Publicado: (2020)

How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives
por: Chester, Thomas, et al.
Publicado: (2023)

Optical Quality and Tear Film Analysis Before and After Intranasal Stimulation in Patients with Dry Eye Syndrome
por: Passi, Samuel F, et al.
Publicado: (2020)

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
por: Sheppard, John, et al.
Publicado: (2021)

Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial
por: Schechter, Barry A, et al.
Publicado: (2022)

An experimental study of amniotic lacrimal duct stents in the treatment of perimenopausal female rabbits with dry eye
por: Ma, Mingyang, et al.
Publicado: (2019)

Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease
por: John, Thomas, et al.
Publicado: (2017)

Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane
por: McDonald, Marguerite, et al.
Publicado: (2023)

Cytokine expression and ultrastructural alterations in fresh-frozen, freeze-dried and γ-irradiated human amniotic membranes
por: Paolin, Adolfo, et al.
Publicado: (2016)

The use of dry amniotic membrane in pterygium surgery
por: Noureddin, Gelareh S, et al.
Publicado: (2016)

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
por: White, Darrell E, et al.
Publicado: (2020)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
por: Rhee, Michelle K, et al.
Publicado: (2017)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
por: Periman, Laura M, et al.
Publicado: (2020)

TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial
por: Gupta, Preeya K., et al.
Publicado: (2022)

Azithromycin in DuraSite(®) for the treatment of blepharitis
por: Luchs, Jodi
Publicado: (2010)

Dry Eye Disease and Tear Cytokine Levels—A Meta-Analysis
por: Roda, Matilde, et al.
Publicado: (2020)

Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndrome
por: Voigt, Jeffrey
Publicado: (2020)

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
por: White, Darrell E, et al.
Publicado: (2020)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
por: Yeu, Elizabeth, et al.
Publicado: (2020)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
por: Schultz, Clyde
Publicado: (2014)

Correlation of interleukin-33 with Th cytokines and clinical severity of dry eye disease
por: Luo, Guoping, et al.
Publicado: (2018)

Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye
por: Uthaithammarat, Lita, et al.
Publicado: (2021)

Management of recalcitrant corneal ulcers with dry processed amniotic membrane
por: Bhatia, Jagdish, et al.
Publicado: (2019)

Amniotic membrane extract and eye drops: a review of literature and clinical application
por: Murri, Michael S, et al.
Publicado: (2018)

The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye
por: Trattler, William B, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t67igi7ajm961b26ejsjj4ntnm